In other words, it means uncertainty about whether the prognosis will be good (bona fide Spitz, with tyrosine kinase fusion), or conversely, the evolution could be more aggressive and eventually lethal (BRAF or NRAS melanoma) (Figure 3). Here, BRAF is linked to melanoma.